ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,173.70
0.18%
S&P ASX All Technology
3,786.30
-0.50%
Brent Oil
73.855
0.00%
US Dollar vs AUD
1.61487
-0.12%
Bitcoin
94,294.85
-0.11%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. NEO

  6. Abbvie CDR (ABBV) Share Price

Abbvie CDR

Abbvie CDR (ABBV)

AbbVie Inc
25.67
0.16
(0.63%)
Closed 02 January 8:00AM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
25.67
Bid
24.80
Offer
28.00
Volume
16,176
25.44 Day's Range 25.67
0.00 52 Week Range 0.00
Previous Close
25.51
Open
25.51
Last Trade
300
@
25.67
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

ABBV Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

19 December 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

17 December 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 December 2024
Edgar (US Regulatory)

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline PR Newswire NORTH CHICAGO, Ill. and MADISON, Wis., Dec. 13, 2024 Proposed acquisition adds Nimble's lead asset, an...

14 December 2024
PR Newswire (US)

AbbVie Completes Acquisition of Aliada Therapeutics

AbbVie Completes Acquisition of Aliada Therapeutics PR Newswire NORTH CHICAGO, Ill., Dec. 11, 2024 Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease...

12 December 2024
PR Newswire (US)

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell...

10 December 2024
PR Newswire (US)

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease PR Newswire NORTH CHICAGO, Ill., Dec. 9, 2024 Tavapadon met...

10 December 2024
PR Newswire (US)

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients PR Newswire NORTH CHICAGO, Ill., Dec. 8, 2024 -New insights show Black, Hispanic, and Asian...

09 December 2024
PR Newswire (US)

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) PR...

08 December 2024
PR Newswire (US)

AbbVie to Present at Citi's 2024 Global Healthcare Conference

AbbVie to Present at Citi's 2024 Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., Nov. 25, 2024 NORTH CHICAGO, Ill., Nov. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will...

26 November 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ABBV - Frequently Asked Questions (FAQ)

What is the current Abbvie CDR share price?
The current share price of Abbvie CDR is $ 25.67
What is the 1 year trading range for Abbvie CDR share price?
Abbvie CDR has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBERIberAmerican Lithium Corp
$ 0.045
(28.57%)
1.96M
CBSTCannabist Company Holdings Inc
$ 0.095
(26.67%)
876.18k
DMETDenarius Metals Corp
$ 0.68
(15.25%)
1.7k
MLCMount Logan Capital Inc
$ 2.73
(9.20%)
14.41k
JETGlobal Crossing Airlines Group Inc
$ 0.65
(8.33%)
31k
BTQBTQ Technologies Corp
$ 3.94
(-17.75%)
1.14M
FHFilament Health Corp
$ 0.03
(-14.29%)
6k
LABZMetaspere Labs Inc
$ 0.09
(-10.00%)
14k
NETZCarbon Streaming Corporation WTS B
$ 0.50
(-5.66%)
75.19k
ABXXAbaxx Technologies Inc
$ 11.07
(-2.04%)
25.77k
IBERIberAmerican Lithium Corp
$ 0.045
(28.57%)
1.96M
BTQBTQ Technologies Corp
$ 3.94
(-17.75%)
1.14M
VERSVerses AI Inc
$ 1.64
(6.49%)
1.04M
CBSTCannabist Company Holdings Inc
$ 0.095
(26.67%)
876.18k
VRNOVerano Holdings Corp
$ 1.76
(5.39%)
656.15k

Discussion

View Full Feed
Filterthenoise Filterthenoise 1 minute ago
FOXHO-HO-HO is a season🎅
RNVA
richdag richdag 2 minutes ago
Legal short sellers were covering the day after NWBO's financing announcement on the 26th as evidenced in my account records for Fri the 27th. As of the close on the 26th, I had 500,500 shares loaned out under Fidelity's Fully Paid Lending Program. Then sometime during the first couple of hours la
NWBO
Hoghead7 Hoghead7 2 minutes ago
1st post shows up on FCE LinkedIn page! I wonder why they haven't posted anything above/afterwards! No I don't. They want to make sure this is what people see. Why. Note Exxonmobil bragging about more than 90% capture!
https://www.linkedin.com/posts/exxonmobil_technology-energytransition
FCEL
TRAPPER JIM TRAPPER JIM 2 minutes ago
It's all good. Bummer you have to work today. Buckeyes are doing great today 
Filterthenoise Filterthenoise 3 minutes ago
No one ever gave a date?
RNVA
TheHound TheHound 3 minutes ago
IPIX gave shareholders the big shaft. Bagholders are screwed.
IPIX
johnydollar johnydollar 3 minutes ago
The truth is very naked......

They wanted revocation.......

It failed......

Now they want bankruptcy.......

And that is the honest truth.......

They never wanted anything better for this company.......

Oh well.
DBMM
blackhawks blackhawks 3 minutes ago
Wow, Elon, flinch much?
Duke Knockem Duke Knockem 3 minutes ago
December 2nd is long gone and still nothing
CERO
mahatmapaul mahatmapaul 4 minutes ago
This post should be stickied ....
SPZI
LVerstee LVerstee 4 minutes ago
Laxmi, you fail to understand that I don’t want anything from you. There is literally you can do to fix things. You do not have the capability norbthe capacity. Earlier, I asked for an apology for continuously labeling me as a criminal, projecting, but the only way you’ll stop is when you’re behind
ITUP
WinstonCup WinstonCup 5 minutes ago
Absolutely, bad opinion for 3 years.
WDLF
Stock_Barber Stock_Barber 5 minutes ago
2025 Will Be Best Year Ever.
That is a very low bar...


https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fwww.icegif.com%2Fwp-content%2Fuploads%2F2023%2F08%2Ficegif-264.gif&f=1&nofb=1&ipt=5c308f745c113bf8217ad80be633f3506ea970dc8b594ee53897cae804ecef09&ipo=imag
DBMM
EternalPatience EternalPatience 5 minutes ago
Do we see our max to be 30-35 based on Ackman or is there a chance if higher? (Alternate outcomes)??  I am thinking Ackman knows how this will end and if he says 34 and 31, it may be close to what and how it will end?
FNMA
RickNagra RickNagra 6 minutes ago
Oh wow. Here we go.
RDAR
al44 al44 6 minutes ago
AOC to the rescue-

https://media.gettr.com/group5/getter/2025/01/01/23/46cea62f-14e1-d93f-498a-33d9488b4778/a4e0bce4622d1fc110e7cd16bf37fc87_768x0.png
WinstonCup WinstonCup 7 minutes ago
Just keeping things balanced.
Happy New Year!
WDLF
NinjaTitan43 NinjaTitan43 7 minutes ago
Isnt survaxm vaccine just way better
NWBO
stockinspector stockinspector 8 minutes ago
Are you a group of diligent detractors? There seems to be concerted effort to use fear tactics based on
partial truths along with a smear campaign against Ken and those who support his efforts.
Why would a small group of traders (4-6) trash their own investment on a public forum?
WDLF
nowwhat2 nowwhat2 8 minutes ago
HNY NYC

https://investorshub.advfn.com/uimage/uploads/2025/1/1/bdbsebtc_!_1_45d_333pm_holy_horiz.jpg



THIS IS THAT LINE UP THERE ;
https://investorshub.advfn.com/uimage/uploads/2025/1/1/jyersbtc_!_1_15d_333pm_HNY_NYC_W_HOLY_HORIZ.jpg
XRPUSD
GetRichLong GetRichLong 9 minutes ago
Slandering will be prosecuted to the fullest extent of the law.
AHRO
WooptdooU WooptdooU 9 minutes ago
Lawyers will cost the GRIFTERS, current, past and ahole x's...Just wait.
LWLG
blackhawks blackhawks 9 minutes ago
You too, champ.
GetRichLong GetRichLong 9 minutes ago
Too much pumping and spam. Be very wary of anyone that is trying to sell you a bridge here.
AHRO
JERSEYHAWG JERSEYHAWG 10 minutes ago
After reading all 23 posts. I can only say one thing for sure.

HAPPY NEW YEAR TO EVERYONE.

OK, back to incognito mode.

😅
LEHNQ

Your Recent History

NEO
ABBV
Abbvie CDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads